Top Markets
Coin of the day
Wuhan General Group (China), Inc. Wuhan General Group (China), Inc.

Wuhan General Group (China), Inc.

WUHN
Rank in Stocks #41554
Wuhan General Group (China), Inc. is a nutraceutical biotechnology company,... Wuhan General Group (China), Inc. is a nutraceutical biotechnology company, which engages in the development of alternative plant-based cannabinoids and psilocybin medical research that commercializes a range of cannabidiol and mushrooms-based products under the Dr. AnnaRx, Medspresso and Handcrafted Delights brands. The firm is also engages in research and development of indications for psilocybin new therapies that will help patients who suffer from mental illness, Alzheimer's and Parkinson's. The company was founded by Xu Jie and Jeff Robinson on July 19, 1988 and is headquartered in Cape Town, South Africa.
Share Price
$0.0003
Last synced: 2026-08-11
Market Cap
$16.55K
Change (1 day)
0.00%
Change (1 year)
200.00%
Country
ZA
Trade Wuhan General Group (China), Inc. (WUHN)

Category

EPS for Wuhan General Group (China), Inc. (WUHN)
EPS as of 2026 TTM: 0
According to Wuhan General Group (China), Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Wuhan General Group (China), Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors